We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of the activity of the Drug Testing on Arrest (DToA) programme since its launch in March 2022.
This page provides a summary of the data returns from the Drug Testing on…
These data tables were published on 29 May 2025, presenting Drug Testing…
Biographies of members of the Advisory Council on the Misuse of Drugs.
The Advisory Council on the Misuse of Drugs makes recommendations to…
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice.
V.2.0 December 2024 Inclusion of Classification chapter (Secretariat:…
Overview of the Advisory Council on the Misuse of Drugs' (ACMD) work from January 2020 to December 2022.
This report sets out progress from the first year of the delivery of the drug strategy, from harm to hope.
First published during the 2022 to 2024 Sunak Conservative government
Information about the data we collect from people in services funded by the rough sleeping drug and alcohol treatment grant.
First published during the 2019 to 2022 Johnson Conservative government
Information about the data we collect as part of the license application process for doctors to prescribe diamorphine to treat opioid dependence.
Why we collect data for the Individual Placement and Support for Alcohol and Drug Dependence (IPS-AD) trial, what we do with it and who we share it with.
The first annual report from the UK Recovery Champion outlines the work he has undertaken since his appointment and sets out his future work programme.
This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment.
A review of the evidence on the 2016 drug strategy by the Advisory Council on the Misuse of Drugs (ACMD).
An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
Minutes of the Advisory Council on the Misuse of Drugs.
Figures on methylphenidate base and methylphenidate hydrochloride importation between 2010 and 2012 were requested.
Information regarding various aspects of the FRANK drugs advisory service.
This publication scheme is in accordance with the ACMD policy on openness and transparency detailed in the ACMD’s Code of Practice.
Agenda details for ACMD meeting on 29 march 2010
In the UK today, a large proportion of young people use tobacco, alcohol and other drugs in the pursuit of pleasure, solace, acceptance or escape…
Request for details of the background that led to David Blunkett's decision to downgrade cannabis from a class B drug to a class C drug.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).